alprazolam c-iv

Generic: alprazolam c-iv

Labeler: direct_rx
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name alprazolam c-iv
Generic Name alprazolam c-iv
Labeler direct_rx
Dosage Form TABLET
Routes
ORAL
Active Ingredients

alprazolam .5 mg/1

Manufacturer
Direct_Rx

Identifiers & Regulatory

Product NDC 72189-442
Product ID 72189-442_36989536-40a1-56fd-e063-6394a90ab396
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203346
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2023-03-14

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72189442
Hyphenated Format 72189-442

Supplemental Identifiers

RxCUI
308048
UNII
YU55MQ3IZY
NUI
N0000175694 M0002356

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alprazolam c-iv (source: ndc)
Generic Name alprazolam c-iv (source: ndc)
Application Number ANDA203346 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 2 TABLET in 1 BOTTLE (72189-442-02)
  • 30 TABLET in 1 BOTTLE (72189-442-30)
  • 90 TABLET in 1 BOTTLE (72189-442-90)
source: ndc

Packages (3)

72189-442-02 2 TABLET in 1 BOTTLE (72189-442-02) 72189-442-30 30 TABLET in 1 BOTTLE (72189-442-30) 72189-442-90 90 TABLET in 1 BOTTLE (72189-442-90)

Ingredients (1)

alprazolam (.5 mg/1)

Linked Drug Pages (1)

Alprazolam C-IV ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "36989536-40a1-56fd-e063-6394a90ab396", "openfda": {"nui": ["N0000175694", "M0002356"], "unii": ["YU55MQ3IZY"], "rxcui": ["308048"], "spl_set_id": ["f6dd0e94-4a79-769f-e053-6394a90a5ae6"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "2 TABLET in 1 BOTTLE (72189-442-02)", "package_ndc": "72189-442-02", "marketing_start_date": "20230314"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-442-30)", "package_ndc": "72189-442-30", "marketing_start_date": "20230314"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (72189-442-90)", "package_ndc": "72189-442-90", "marketing_start_date": "20230314"}], "brand_name": "Alprazolam C-IV", "product_id": "72189-442_36989536-40a1-56fd-e063-6394a90ab396", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "72189-442", "dea_schedule": "CIV", "generic_name": "Alprazolam C-IV", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alprazolam C-IV", "active_ingredients": [{"name": "ALPRAZOLAM", "strength": ".5 mg/1"}], "application_number": "ANDA203346", "marketing_category": "ANDA", "marketing_start_date": "20230314", "listing_expiration_date": "20261231"}